Future research in immunology for composite tissue allotransplantation;Les voies de recherche en immunologie appliquées à l'allotransplantation de tissus composites

Annales de Chirurgie Plastique Esthetique

Volumn 51, Issue 1, 2006, Pages 11-17

  Petit, F ^a,b   Lantieri, L ^b   Randolph, M A ^a   Lee, W P A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Chimerism; Composite tissue allotransplantation; Experimental research; Hematopoietic; Immunosuppression; Rejection; Tolerance

Indexed keywords

15 DEOXYSPERGUALIN; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT;

ALLOTRANSPLANTATION; BONE MARROW CELL; CHIMERA; CHRONIC GRAFT REJECTION; COMPOSITE GRAFT; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL RESEARCH; NONHUMAN; PLASTIC SURGERY; REVIEW; SIDE EFFECT;

EID: 33644962495     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2005.10.002     Document Type: Short Survey

References (31)

1. F. Petit, L. Lantieri, J.C. Guimberteau, D. Hannouche, and W.P. Lee Allotransplantation de tissus composites et chirurgie reconstructrice:: les premìres applications cliniques Ann. Chir. Plast. Esth́t. 47 2002 222 231
2. J.M. Dubernard, E.R. Owen, M. Lanzetta, and N. Hakim What is happening with hand transplants Lancet 357 2001 1711 1712
3. H.J. Auchincloss, M. Sykes, and D.H. Sachs Transplantation immunology Fundamental immunology 1999 Lippincott-Raven Philadelphia 1175 1235
4. R.E. Billingham, L. Brent, and P.B. Medawar Actively acquired tolerance of foreign cells Nature 1953 603
5. S.T. Ildstad, and D.H. Sachs Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts Nature 307 1984 168 170
6. L.Y. Leong, S. Qin, S.P. Cobbold, and H. Waldmann Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression Eur. J. Immunol. 22 1992 2825 2830
7. Y. Sharabi, and D.H. Sachs Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen J. Exp. Med. 169 1989 493 502
8. M. Sykes, G.L. Szot, K.A. Swenson, and D.A. Pearson Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning Nat. Med. 3 1997 783 787
9. C.A. Huang, Y. Fuchimoto, R. Scheier-Dolberg, M.C. Murphy, D.M. Neville Jr., and D.H. Sachs Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model J. Clin. Invest. 105 2000 173 181
10. Y. Fuchimoto, C.A. Huang, K. Yamada, A. Shimizu, H. Kitamura, and R.B. Colvin Mixed chimerism and tolerance without whole body irradiation in a large animal model J. Clin. Invest. 105 2000 1779 1789
11. T. Kawai, A. Poncelet, D.H. Sachs, S. Mauiyyedi, S. Boskovic, and S.L. Wee Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance Transplantation 68 1999 1767 1775
12. T.R. Spitzer, F. Delmonico, N. Tolkoff-Rubin, S. McAfee, R. Sackstein, and S. Saidman Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism Transplantation 68 1999 480 484
13. A.B. Cosimi Non-myeloablative bone marrow transplantation for tolerance induction. In converging therapies: the role of mixed chimerism in transplantation tolerance and in the treatment of hematologic malignancies 2001
14. W.P. Lee, M.J. Yaremchuk, Y.C. Pan, M.A. Randolph, C.M. Tan, and A.J. Weiland Relative antigenicity of components of a vascularized limb allograft Plast. Reconstr. Surg. 87 1991 401 411
15. D.W. Mathes, K. Yamada, M.A. Randolph, R. Utsugi, M.G. Solari, and G.S. Gazelle In utero induction of transplantation tolerance Transplant. Proc. 33 2001 98 100
16. R.D. Foster, L. Fan, M. Neipp, C. Kaufman, T. McCalmont, and N. Ascher Donor-specific tolerance induction in composite tissue allografts.[corrected; erratum to be published] Am. J. Surg. 176 1998 418 421
17. C.P. Larsen, E.T. Elwood, D.Z. Alexander, S.C. Ritchie, R. Hendrix, and C. Tucker-Burden Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways Nature 381 1996 434 438
18. A.D. Kirk, L.C. Burkly, D.S. Batty, R.E. Baumgartner, J.D. Berning, and K. Buchanan Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates Nat. Med. 5 1999 686 693
19. T.H. Tung, T. Mohanakumar, and S.E. Mackinnon Tolerance induction using anti-CD40L antibody in a new murine limb transplantation model. In Chicago, Milwaukee: American Society of Transplantation; Plastic Surgery Research Council 2001
20. W.P. Lee, J.P. Rubin, J.L. Bourget, S.R. Cober, M.A. Randolph, and G.P. Nielsen Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens Plast. Reconstr. Surg. 107 2001 1482 1490 (discussion 1491-2)
21. S.M. Katz, J.C. Hong, and B.D. Kahan New immunosuppressive agents Transplant. Proc. 32 2000 620 621
22. B.D. Kahan FTY720: a new immunosuppressive agent with novel mechanism(s) of action Transplant. Proc. 30 1998 2210 2213
23. J.M. Thomas, D.E. Eckhoff, J.L. Contreras, A.L. Lobashevsky, W.J. Hubbard, and J.K. Moore Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy Transplantation 69 2000 2497 2503
24. R. Calne, S.D. Moffatt, P.J. Friend, N.V. Jamieson, J.A. Bradley, and G. Hale Campath-1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients Transplantation 68 1999 1613 1616
25. Y. Vanrenterghem, Y. Lebranchu, R. Hene, F. Oppenheimer, and H. Ekberg Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection Transplantation 2000 1352 1359
26. E. Morelon, and H. Kreis New immunosuppressive agents: a way to get rid of corticosteroids? Transplantation 70 2000 1271 1272
27. C.G. Francois, W.C. Breidenbach, C. Maldonado, T.P. Kakoulidis, A. Hodges, and J.M. Dubernard Hand transplantation: comparisons and observations of the first four clinical cases Microsurgery 20 2000 360 371
28. A. Panhans-Groß, N. Novak, S. Kraft, and T. Bieber Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506) J. Allergy Clin. Immunol. 107 2001 345 352
29. A. Wollenberg, S. Sharma, D. Von Bubnoff, E. Geiger, J. Haberstok, and T. Bieber Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis J. Allergy Clin. Immunol. 107 2001 519 525
30. R.D. Granstein, L. Smith, and J.A. Parrish Prolongation of murine skin allograft survival by the systemic effects of 8-methoxypsoralen and long-wave ultraviolet radiation (PUVA) J. Invest. Dermatol. 88 1987 424 429
31. H.J. Deeg Ultraviolet irradiation in transplantation biology. Manipulation of immunity and immunogenicity Transplantation 45 1988 845 851